
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
COMPARATIVE EFFICACY AND SAFETY OF INTRAMUSCULAR MIDAZOLAM VERSUS INTRAVENOUS LORAZEPAM IN PREHOSPITAL MANAGEMENT OF STATUS EPILEPTICUS: EVIDENCE FROM RAMPART TRIAL
P. Priyadharshini*, S. Lakshmi, V. Anushree, M. Praveenkumar, C. Jothimanivannan
Abstract Background: Status Epilepticus (SE) is a life-threatening neurological emergency that requires immediate treatment. Intravenous (IV) lorazepam is a standard first-line therapy, but IV access is often delayed in Prehospital settings. Intramuscular (IM) Midazolam offers a potential alternative due to its ease of administration. Objective: To evaluate and compare the effectiveness of IM midazolam and IV lorazepam in terminating seizures in patients with status epilepticus in a Prehospital setting. Keywords: Status epilepticus (SE), Intramuscular (IM) midazolam, Intravenous (IV) Lorazepam, Emergency Medical Services (EMS), seizure treatment, neurological emergencies. [Full Text Article] [Download Certificate] |
